Vulvovaginal candidiasis resistant to azoles [2];Candidiasis vulvovaginal resistente a azoles

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 18, Issue 7, 2000, Pages 367-368

  Garcia Martos P ^a   Dominguez I ^a   Merin P ^a   Garcia Agudo L ^a   Mira, J ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; PROTEINASE;

BACTERIUM ADHERENCE; CANDIDA ALBICANS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DRUG SENSITIVITY; DRUG USE; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LETTER; MINIMUM INHIBITORY CONCENTRATION; ORAL CONTRACEPTION; PH; SACCHAROMYCES CEREVISIAE; VAGINA CANDIDIASIS; VAGINA EPITHELIUM;

ANTIBIOTICS, ANTIFUNGAL; AZOLES; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; SACCHAROMYCES CEREVISIAE;

EID: 0034484706     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy
2. Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic
3. Vaginitis por Saccharomyces cerevisiae
4. Vaginitis due to Saccharomyces cerevisiae: Epidemiology, clinical aspects, and therapy
5. Multi-center comparison of the Sensititre Yeast One Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms
6. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates
7. Treatment of Torulopsis glabrata vaginitis: Retrospective review of boric acid therapy
8. Update on treatment of vulvovaginal candidiasis
9. Vulvovaginitis due to Candida glabrata. An emerging problem
10. Vulvovaginalmykosen